• Home
  • Agric
  • Sci & Tech
  • Health
  • Environment
  • Hausa News
  • More
    • Business/Banking & Finance
    • POLITICS
    • Entertainments & Sports
    • International
    • Investigation
    • Law & Human Rights
    • Africa
    • ACCOUNTABILITY/CORRUPTION
    • Hassan Gimba
    • Column
    • Prof. Jibrin Ibrahim
    • Prof. M.K. Othman
    • Defense/Security
    • Education
    • Energy/Electricity
    • Entertainment/Arts & Sports
    • Society and Lifestyle
    • Food & Agriculture
    • Health & Healthy Living
    • International News
    • Interviews
    • Investigation/Fact-Check
    • LAW & HUMAN RIGHTS
    • Oil & Gas/Mineral Resources
    • PRESS FREEDOM/JOURNALISM/PR
    • General News
    • Presidency
  • About Us
    • Contact Us
    • Board Of Advisory
    • Privacy Policy
    • Ethics Policy
    • Teamwork And Collaboration Policy
    • Fact-Checking Policy
    • Advertising
  • Media OutReach Newswire
    • Wire News
  • The Stories
Facebook Twitter Instagram
Trending
  • Nigeria receives $11.12bn in personal transfers, workers’ remittances in H1 2026
  • Tinubu calls for end to Africa’s mineral exploitation
  • Enugu hires over 160 livestock professionals
  • Sebore farm, Gates foundation empower 279 dairy farmers
  • Lions Clubs urge journalists to prioritise health checks
  • NSITF transforms operations through digitalisation, restructuring – MD
  • UI don says certified yam seed yam will boost production, exports
  • WHO advances talks on pathogen access system for pandemics
Facebook Twitter Instagram YouTube
AsheNewsAsheNews
  • Home
  • Agric

    Enugu hires over 160 livestock professionals

    September 22, 2026

    Sebore farm, Gates foundation empower 279 dairy farmers

    September 22, 2026

    UI don says certified yam seed yam will boost production, exports

    September 21, 2026

    Kwara launches cattle AI programme

    September 21, 2026

    Lagos residents raise concerns over unsafe fufu preparation

    September 20, 2026
  • Sci & Tech

    Nwifuru woos auto investors as NADDC centre opens in Ebonyi

    September 19, 2026

    King Charles warns of AI risks

    September 17, 2026

    Pope Leo XIV cautions against leaving human decisions to AI algorithms

    September 17, 2026

    Hackathons should lead to real solutions, not just prizes – Codefest co-founder

    September 17, 2026

    Experts call for stronger investment, skills and policies at TSSF 7.0

    September 17, 2026
  • Health

    Lions Clubs urge journalists to prioritise health checks

    September 22, 2026

    WHO advances talks on pathogen access system for pandemics

    September 21, 2026

    Fagbemi brings free healthcare to Ijagbo community

    September 21, 2026

    Global Shapers Kano urge voluntary blood donation

    September 21, 2026

    YabaTech Rector urges Nigerians to revive walking culture

    September 21, 2026
  • Environment

    Tinubu calls for end to Africa’s mineral exploitation

    September 22, 2026

    NSITF transforms operations through digitalisation, restructuring – MD

    September 22, 2026

    Fuel price hikes deepen hardship for FCT residents

    September 21, 2026

    Lagos directs residents to higher ground

    September 21, 2026

    NiMet forecasts thunderstorms nationwide

    September 21, 2026
  • Hausa News

    UNA signs MoU to launch air Bissau in Guinea-Bissau

    June 15, 2026

    Otti plans 250-room 5-star hotel in Umuahia

    April 11, 2026

    Anti-quackery task force seals 4 fake hospitals in Rivers

    August 29, 2025

    [BIDIYO] Yadda na lashe gasa ta duniya a fannin Ingilishi – Rukayya ‘yar shekara 17

    August 6, 2025

    A Saka Baki, A Sasanta Saɓani Tsakanin ‘Yanjarida Da Liman, Daga Muhammad Sajo

    May 21, 2025
  • More
    1. Business/Banking & Finance
    2. POLITICS
    3. Entertainments & Sports
    4. International
    5. Investigation
    6. Law & Human Rights
    7. Africa
    8. ACCOUNTABILITY/CORRUPTION
    9. Hassan Gimba
    10. Column
    11. Prof. Jibrin Ibrahim
    12. Prof. M.K. Othman
    13. Defense/Security
    14. Education
    15. Energy/Electricity
    16. Entertainment/Arts & Sports
    17. Society and Lifestyle
    18. Food & Agriculture
    19. Health & Healthy Living
    20. International News
    21. Interviews
    22. Investigation/Fact-Check
    23. LAW & HUMAN RIGHTS
    24. Oil & Gas/Mineral Resources
    25. PRESS FREEDOM/JOURNALISM/PR
    26. General News
    27. Presidency
    Featured
    Recent

    Nigeria receives $11.12bn in personal transfers, workers’ remittances in H1 2026

    September 22, 2026

    Tinubu calls for end to Africa’s mineral exploitation

    September 22, 2026

    Enugu hires over 160 livestock professionals

    September 22, 2026
  • About Us
    1. Contact Us
    2. Board Of Advisory
    3. Privacy Policy
    4. Ethics Policy
    5. Teamwork And Collaboration Policy
    6. Fact-Checking Policy
    7. Advertising
    Featured
    Recent

    Nigeria receives $11.12bn in personal transfers, workers’ remittances in H1 2026

    September 22, 2026

    Tinubu calls for end to Africa’s mineral exploitation

    September 22, 2026

    Enugu hires over 160 livestock professionals

    September 22, 2026
  • Media OutReach Newswire
    • Wire News
  • The Stories
AsheNewsAsheNews
Home»Health & Healthy Living»[EXPLAINER] List of drugs linked to dementia, By Nicole Rowe
Health & Healthy Living

[EXPLAINER] List of drugs linked to dementia, By Nicole Rowe

EditorBy EditorFebruary 16, 2026Updated:February 16, 2026No Comments5 Mins Read
Dementia
Share
Facebook Twitter LinkedIn Pinterest Email

Key takeaways: Certain medications are linked to an increased risk of dementia. But that doesn’t mean they necessarily cause dementia.

  • Medications that have been associated with increased risk of dementia include overactive bladder medications, pain medications, heartburn medications, and certain anxiety medications.
  • The risk of dementia with these medications increases when you take higher doses over longer periods of time.
  • Dementia is a growing concern among many aging people in the U.S., especially Alzheimer’s disease. And since treatment options for dementia are limited, prevention is key. 
  • Dementia risk is tied to common things like diabetes, high blood pressure, and physical inactivity. But some common medications are associated with dementia risk, too. Here are four common drug classes linked to dementia, and what the research says about your risk.

1. Anticholinergic medications

  • Anticholinergic medications block a chemical called acetylcholine in the body. Acetylcholine works like a chemical messenger in the nervous system. It affects learning, memory, movement, and even emotions. And people with Alzheimer’s disease often have low levels of acetylcholine in their bodies. 
  • In one large study of almost 300,000 people, the risk of dementia was significantly higher in those who had taken the highest cumulative doses of strong anticholinergic medications.  Another large study in adults over 65 years old confirmed these findings. Other studies have shown that the use of an anticholinergic medication can worsen dementia in people who are already experiencing cognitive decline.  
  • But not all studies have such clear-cut findings. For example, even though diphenhydramine (Benadryl) has strong anticholinergic activity, current research is unclear on whether diphenhydramine increases the risk of dementia. 
  • Some common anticholinergic medications include antihistamines, tricyclic antidepressants, medications for irritable bowel syndrome (IBS), and overactive bladder medications. You may want to take this risk into account if you’re deciding whether to take these medications.

Antihistamine medications include: 

  • Diphenhydramine (Benadryl, Advil PM, Tylenol PM)
  • Chlorpheniramine (Chlor-tab, Aller-Chlor, Coricidin HBP)
  • Doxylamine (Unisom)

Tricyclic antidepressants include: 

  • Doxepin (Silenor) 
  • Nortriptyline (Pamelor) 
  • Amitriptyline (Elavil)

IBS medications include: 

  • Hyoscyamine (Levsin) 
  • Dicyclomine (Bentyl)

Overactive bladder medications include:

  • Darifenacin ER (Enablex)
  • Oxybutynin (Ditropan)
  • Tolterodine (Detrol, Detrol LA)
  • Trospium (Sanctura)
  • Solifenacin (Vesicare)
  • Fesoterodine (Toviaz)

2. Proton pump inhibitors

Studies suggest that men and women with dementia are more likely to be taking proton pump inhibitors (PPIs), 1.5 and 1.4 times, respectively. This doesn’t necessarily mean that PPIs directly cause dementia — only that there appears to be an association between the two. There are a couple of theories about how these medications could increase dementia risk:

  • PPIs have been shown to cause proteins, called β-amyloid plaques, to build up in the brains of mice. This is similar to the way someone’s brain changes with Alzheimer’s. 
  • Long-term use of PPIs could affect the absorption of vitamin B12, which could also increase your risk for dementia.

PPIs include:

  • Omeprazole (Prilosec)
  • Lansoprazole (Prevacid)
  • Esomeprazole (Nexium)
  • Pantoprazole (Protonix)

3. Pain medications

Many people are aware that the use of opioid pain medications can lead to dependence, overdose, and even death. But in addition to these concerns, studies show that people with heavy, long-term use of opioid medications have a slightly higher risk of getting dementia. Even people taking nonsteroidal anti-inflammatory drugs (NSAIDs) for pain had a high risk of developing dementia. 

It’s unclear whether the risk of dementia is related to taking pain medication or to the effects of chronic pain on the brain, or both. One newer study showed that older adults with chronic pain had a higher risk of developing dementia. This study didn’t measure how many of these adults were taking pain medications, so additional research is needed. 

Opioid medications include: 

  • Morphine
  • Hydrocodone (Norco)
  • Hydromorphone (Dilaudid)
  • Fentanyl (Duragesic)

NSAIDs include:

  • Naproxen (Aleve, Naprosyn)
  • Ibuprofen (Motrin, Advil)
  • Indomethacin (Indocin)

4. Benzodiazepines

Benzodiazepines (benzos) have been linked to dementia — especially in older adults. But not all research supports this link. 

Regardless, older adults should be cautious with these medications. Benzodiazepines can cause many other concerning side effects, including long-term dependence, breathing problems, confusion, drowsiness, problems with cognition, and even death. The risk for impaired brain functioning is increased with higher doses over an extended period of time.

Benzodiazepine medications include:

  • Lorazepam (Ativan)
  • Clonazepam (Klonopin)
  • Diazepam (Valium)
  • Alprazolam (Xanax, Niravam)

The bottom line

Many medications have been associated with an increased risk of dementia — especially if you take them for a long time. As with any medication, it’s important to weigh the pros and cons to figure out what’s best for you and your long-term health. 

If you rely on any of these medications to stay healthy, work with a healthcare professional to determine the lowest dose that will still treat your symptoms. This will decrease your risk of any associated side effects, including dementia.  

Dr. Nicole Rowe, MD, is a telehealth family practice physician. She received her medical degree from the University of North Carolina School of Medicine and completed her residency in family medicine atthe University of Colorado’s Swedish Medical Center.

Dementia drugs
Share. Facebook Twitter Pinterest LinkedIn WhatsApp Reddit Tumblr Email
Editor
  • Website

Related Posts

Lions Clubs urge journalists to prioritise health checks

September 22, 2026

WHO advances talks on pathogen access system for pandemics

September 21, 2026

Fagbemi brings free healthcare to Ijagbo community

September 21, 2026

Leave A Reply Cancel Reply

Nigeria receives $11.12bn in personal transfers, workers’ remittances in H1 2026

September 22, 2026

Tinubu calls for end to Africa’s mineral exploitation

September 22, 2026

Enugu hires over 160 livestock professionals

September 22, 2026

Sebore farm, Gates foundation empower 279 dairy farmers

September 22, 2026
About Us
About Us

ASHENEWS (AsheNewsDaily.com), published by PenPlus Online Media Publishers, is an independent online newspaper. We report development news, especially on Agriculture, Science, Health and Environment as they affect the under-reported rural and urban poor.

We also conduct investigations, especially in the areas of ASHE, as well as other general interests, including corruption, human rights, illicit financial flows, and politics.

Contact Info:
  • 1st floor, Dogon Daji House, No. 5, Maiduguri Road, Sokoto
  • +234(0)7031140009
  • ashenewsdaily@gmail.com
Facebook Twitter Instagram Pinterest
© 2026 All Rights Reserved. ASHENEWS Daily Designed & Managed By DeedsTech

Type above and press Enter to search. Press Esc to cancel.